Back to Search
Dossier
TREATING PATIENTS HARBORING AN ISOCITRATE DEHYDROGENASE-1 (IDH-1) MUTATION
InventionPending
22Claims · 2 independent
§ Ⅰ
Dossier Overview
Applicant
FORMA Therapeutics, Inc.
Inventor
Patrick F. Kelly; Alan Collis; Jeff Davis; Duncan Walker; Susan Ashwell; Blythe Thomson; Wei Lu
IPC Classification
A61K 31/4709A61P 35/2C12Q 1/686C12Q 1/6886
CPC Classification
A61K31/4709A61P35/2C12Q1/686C12Q1/6886C12Q2531/113C12Q2561/113C12Q2600/156
Methods of treating patients diagnosed with AML or MDS harboring mutant IDH-1 include detecting an IDH1 mutation and the therapeutic administration of an inhibitor of a mutant IDH-1 as a single agent, or in combination with azacitidine (AZA) or cytarabine.
Original (Chinese)
Methods of treating patients diagnosed with AML or MDS harboring mutant IDH-1 include detecting an IDH1 mutation and the therapeutic administration of an inhibitor of a mutant IDH-1 as a single agent, or in combination with azacitidine (AZA) or cytarabine.
External Resources